$INMB
INmune Bio Inc. Common stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$1.86
▼-0.53%-$0.010
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateINmune Bio Inc. Common stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is INMB down today? It is at $1.86 (-0.53%), and our scanner flagged it 25 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment INMB spikes, and full due diligence on INMB — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $INMB 25 times in the last 30 days. Create a free account to track $INMB, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on INMB from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for INMB today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Moss David J Officer | Other | 9K 0.03% of company | added 0.7% | 1.29M | $13K at $1.40 | Jul 2, 26 |
Lowdell Mark William Officer | Other | 7K 0.03% of company | added 0.5% | 1.52M | $10K at $1.40 | Jul 2, 26 |
Juda Scott Director | Other | 15K 0.05% of company | added 21% | 86K | $21K at $1.40 | Jul 2, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on INMB from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for INMB today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
INMB last traded at $1.86, down 0.53% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
INmune Bio Inc. Common stock (INMB) is next expected to report earnings on Thursday, October 29, 2026, about 22 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The INMB Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged INMB 25 times in the last 30 days.
INMB (INmune Bio Inc. Common stock) trades on XNAS, with a market cap of about $52M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge INMB for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$INMB discussion
Sign in to ask a question or join the discussion.